Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
54.10    0.20 (0.37%)
Bid:
54.10
Ask:
54.60
Spread: 0.50 (0.924%)
Market Cap: £342.43m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Holding(s) in Company

1 Mar 2007 18:38

Marston's PLC01 March 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): MARSTON'S PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) ................. 3. Full name of person(s) subject to the notification obligation (iii): AXA S.A. 25 Avenue Matignon, 75008 Paris and its group of companies 4. Full name of shareholder(s) (if different from 3.) (iv): ................. 5. Date of the transaction and date on which the threshold is crossed or reachedif different) (v): 27/02/2007 6. Date on which issuer notified: 28/02/2007 7. Threshold(s) that is/are crossed or reached: 12% 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction (vi) Number of shares Number of voting Rights (viii) B1JQDM8 36,011,320 36,011,320 Resulting situation after the triggering transaction (vii) Class/type of shares Number of shares Number of voting rights % of voting rights if possible using (ix) the ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect B1JQDM8 3,921,636 3,921,636 33,251,984 1.30 11.06 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Date Exercise/Conversion Number of voting % of voting financial (xiii) Period/ Date (xiv) rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 37,173,620 12.37% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Please note that this notification includes a disclosure on behalf of thefollowing Investment Trust Companies which has/have a notifiable interest asoutlined in the attached appendix. The interest of each Trust is listed below - Framlington Income & Capital: - 0.158% Holding Name of the Company / Fund Number of Shares % of issued share capital AXA Sun Life plc 725,000 0.24119(fmly Axa Equity & Law Life Assurance Society plc) Direct AXA Rosenberg 377,600 0.12562 Direct AXA UK Investment Co ICVC 50,000 0.01663Ethical Fund Indirect AXA UK Investment Co ICVC 50,000 0.01663UK Growth Fund Indirect PPP Healthcare Group plc 20,060 0.00667 Indirect AXA Rosenberg 283,200 0.09421 Direct AXA Insurance UK 189,740 0.06312 Direct AXA Financial, Inc 28,502,788 9.48203 Indirect AXA Colonia Konzern 5,000 0.00166 Indirect AXA Rosenberg 4,580,936 1.52394 Indirect Sun Life Pensions Management Ltd 6,000 0.00200 Direct Sun Life Pensions Management Ltd 10,848 0.00361 Direct Sun Life Unit Assurance Ltd 60,176 0.02002LTAV UK Equity Direct Sun Life Unit Assurance Ltd 161,600 0.05376ABL High Alpha Direct Sun Life Unit Assurance Ltd 57,588 0.01916FTSE All Share Tracker Direct Sun Life Pensions Management 270,468 0.08098LTAV UK Equity Direct Sun Life Pensions Management 778,800 0.25908ABL High Alpha Direct Sun Life Pensions Management 256,088 0.08519FTSE All Share Trackor Direct AXA Framlington 476,200 0.15842Framlington Income & Capital Direct Framlington onshore private clients 43,200 0.01437 Indirect AXA Winterthur 268,328 0.08926 Direct Total Direct 3,921,636 1.30461Total Indirect 33,251,984 11.06195 TOTAL 37,173,620 12.36656 Proxy Voting: 10. Name of the proxy holder: ................. 11. Number of voting rights proxy holder will cease to hold: ................. 12. Date on which proxy holder will cease to hold voting rights: ................. 13. Additional information: ................. 14. Contact name: ................. 15. Contact telephone number: ................. Annex Notification Of Major Interests In Shares (XVI) A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities): AXA S.A. and its group of companies Contact address (registered office for legal entities): 25 Avenue Matignon, 75008 Paris Phone number: ................. Other useful information (at least legal representative for legal persons): ................. B: Identity of the notifier, if applicable (xvii) Full name: Terry Marsh Contact address: 7 Newgate Street, London EC1A 7NX, UK Phone number: 020 7003 2637 Other useful information (e.g. functional relationship with the person or legalentity subject to the notification obligation): AXA IM UK is a 100% direct subsidiary of AXA IM S.A., which is in turn indirectly wholly owned by AXA S.A. C: Additional information : ................. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jul 20268:43 amRNSDirector/PDMR Shareholding
1st Jul 202612:27 pmRNSTotal Voting Rights
22nd Jun 20263:44 pmRNSHolding(s) in Company
1st Jun 20262:38 pmRNSTotal Voting Rights
19th May 202611:12 amRNSDirector Declaration
12th May 20267:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 28 MARCH 2026
1st Apr 20263:12 pmRNSTotal Voting Rights
2nd Mar 202611:43 amRNSTotal Voting Rights
23rd Feb 20265:33 pmRNSHolding(s) in Company
11th Feb 202611:21 amRNSDirector/PDMR Shareholding
2nd Feb 20263:28 pmRNSTotal Voting Rights
28th Jan 202612:37 pmRNSResult of AGM
28th Jan 20267:00 amRNSTrading update for the 17 weeks to 24 January 2026
12th Jan 20262:00 pmRNSBlock listing Interim Review
9th Jan 20269:30 amRNSPurchase of shares into the EBT
2nd Jan 20262:55 pmRNSTotal Voting Rights
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
12th Dec 202511:07 amRNSAnnual Financial Report
11th Dec 20259:54 amRNSPurchase of shares into the EBT
1st Dec 20254:15 pmRNSTotal Voting Rights
28th Nov 202512:36 pmRNSDirector/PDMR Shareholding
28th Nov 202512:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSPRELIMINARY RESULTS
28th Oct 20254:54 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSTrading Update for 52 weeks to 27 September 2025
1st Oct 20254:16 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
1st Aug 20254:17 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTrading Update for the 41 weeks to 12 July 2025
9th Jul 20252:35 pmRNSBlock listing Interim Review
1st Jul 20255:03 pmRNSTotal Voting Rights
26th Jun 20257:05 amRNSAppointment of Chief Financial Officer
13th May 20257:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 29 MARCH 2025
1st May 20253:04 pmRNSTotal Voting Rights
1st Apr 20251:40 pmRNSTotal Voting Rights
20th Mar 202512:48 pmRNSPurchase of shares into the EBT
17th Mar 20251:10 pmRNSPurchase of shares into the EBT
4th Mar 20257:00 amRNSDirectorate Change
25th Feb 20259:24 amRNSHolding(s) in Company
21st Jan 20253:21 pmRNSResult of AGM
21st Jan 20257:00 amRNSTrading Update for the 16 weeks to 18 January 2025
13th Jan 20253:36 pmRNSPurchase of shares into the EBT
10th Jan 202510:13 amRNSBlock listing Interim Review
8th Jan 202511:55 amRNSHolding(s) in Company
2nd Jan 202511:27 amRNSTotal Voting Rights
23rd Dec 202412:15 pmRNSDirector/PDMR Shareholding
20th Dec 202410:47 amRNSPurchase of shares into the EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.